00000nam 2200000zi 4500 9.917447 CaOODSP 20240326093206 m o d f cr cn||||||||| 221117t20222022onc o f000 0 eng d 9780660463018 CaOODSP eng rda CaOODSP n-cn--- HP2-4/2020E-1-PDF Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2020 : executive summary and key findings. Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, 2022. ©2022 1 online resource (4 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. "Publication date: December 2022." Issued also in French under title: Programme intégré canadien de surveillance de la résistance aux antimicrobiens (PICRA) 2020 : sommaire et faits saillants. "The Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) monitors trends in antimicrobial use (AMU) and antimicrobial resistance (AMR) in select foodborne bacterial species from people, animal, and food sources across Canada"--Page 1. Canadian Integrated Program for Antimicrobial Resistance Surveillance. Drug resistance in microorganisms Canada. Anti-infective agents Canada. Public Health Agency of Canada, issuing body. Programme intégré canadien de surveillance de la résistance aux antimicrobiens (PICRA) 2020 : (CaOODSP)9.917449 Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) : 2022 (CaOODSP)9.933607 CIPARS 2019 : (CaOODSP)9.905137 PDF 542 KB https://publications.gc.ca/collections/collection_2023/aspc-phac/HP2-4-2020-1-eng.pdf HTML N/A https://www.canada.ca/en/public-health/services/publications/drugs-health-products/canadian-integrated-program-antimicrobial-resistance-surveillance-2020-executive-summary-key-findings.html 220586